ENVB insider transaction filings
Enveric Biosciences, Inc. — 18 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-03. Screen ENVB transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-03 | 4 | DeWitt Sheila — Director | Grant/award (A): 18,518 @ $0 | EDGAR |
| 2026-06-03 | 4 | Coveney Kevin Michael — Chief Financial Officer | Grant/award (A): 133,333 @ $0 | EDGAR |
| 2026-06-03 | 4 | Facchini Peter J. — Chief Innovation Officer | Grant/award (A): 25,000 @ $0 | EDGAR |
| 2026-06-03 | 4 | Tucker Joseph Edward — Chief Executive Officer, Director | Grant/award (A): 201,124 @ $0 | EDGAR |
| 2026-06-03 | 4 | Kegler George A. — Director | Grant/award (A): 18,518 @ $0 | EDGAR |
| 2026-06-03 | 4 | Schabacker Marcus — Director | Grant/award (A): 18,518 @ $0 | EDGAR |
| 2026-06-03 | 4 | PASQUALONE FRANK — Director | Grant/award (A): 18,518 @ $0 | EDGAR |
| 2026-06-03 | 4 | WEBB MICHAEL D — Director | Grant/award (A): 18,518 @ $0 | EDGAR |
| 2025-12-30 | 4 | DeWitt Sheila — Director | Grant/award (A): 7,633 @ $0 | EDGAR |
| 2025-12-30 | 4 | Coveney Kevin Michael — Chief Financial Officer | Grant/award (A): 40,198 @ $0 | EDGAR |
| 2025-12-30 | 4 | Tucker Joseph Edward — Chief Executive Officer, Director | Grant/award (A): 60,296 @ $0 | EDGAR |
| 2025-12-30 | 4 | Kegler George A. — Director | Grant/award (A): 7,633 @ $0 | EDGAR |
| 2025-12-30 | 4 | Schabacker Marcus — Director | Grant/award (A): 7,633 @ $0 | EDGAR |
| 2025-12-30 | 4 | PASQUALONE FRANK — Director | Grant/award (A): 7,633 @ $0 | EDGAR |
| 2025-12-30 | 4 | WEBB MICHAEL D — Director | Grant/award (A): 7,633 @ $0 | EDGAR |
| 2025-05-12 | 4 | Coveney Kevin Michael — CHIEF FINANCIAL OFFICER | Grant/award (A): 74,150 @ $0 | EDGAR |
| 2025-05-12 | 4 | Facchini Peter J. — CHIEF INNOVATION OFFICER | Grant/award (A): 24,717 @ $0 | EDGAR |
| 2025-05-12 | 4 | Tucker Joseph Edward — CHIEF EXECUTIVE OFFICER, Director | Grant/award (A): 98,866 @ $0 | EDGAR |
Recent 8-K events — Enveric Biosciences, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-09 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-09 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-29 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-15 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-30 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-27 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-06 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-28 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ENVB returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →